Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Clesrovimab-cfor bulk supplier for pharma manufacturers

Clesrovimab-Cfor 105 mg Suppliers & Bulk Manufacturers

Available Forms: injection (prefilled syringe)

Available Strengths: 105 mg

Reference Brands: Enflonsia (USA)

Category: Immune Disorder

Clesrovimab-cfor is a long-acting monoclonal antibody directed against the fusion (F) protein of Respiratory Syncytial Virus (RSV), designed for passive immunization of neonates and infants during or entering their first RSV season. It binds a conserved epitope on the RSV F protein, thereby preventing viral entry, and is given as a single-dose IM injection providing protection throughout a typical 5-month RSV season.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Clesrovimab-Cfor — third party manufacturing & bulk supply

Clesrovimab-Cfor 105 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Clesrovimab-Cfor is supplied as injection (prefilled syringe) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Clesrovimab-Cfor listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Clesrovimab-Cfor →
Back to Listing

Frequently Asked Questions

Clesrovimab-cfor is listed as injection (prefilled syringe) in 105 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Clesrovimab-cfor is referenced against Enflonsia (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Etrasimod Arginine

Strength:
2 mg, 4 mg, 6 mg

Form: Tablets

Reference Brands: Velsipity (USA)

View Details
Avacopan

Strength:
10 mg

Form: Capsules

Reference Brands: Tavneos (USA/EU)

View Details
Fostamatinib Disodium

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Tavalisse (USA)

View Details
Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.